JUPITER NEUROSCIENCES, INC. Cost of Revenue
JUPITER NEUROSCIENCES, INC. (JUNS) reported Cost of Revenue of $3.18 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $3.18K.
- JUPITER NEUROSCIENCES, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $4.36K.
- JUPITER NEUROSCIENCES, INC. cost of goods and services sold for fiscal 2025 was $4.23K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|
| 2026-06-30 | $3.18K 10-Q · filed 2026-08-14 | $7.54K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.36K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $4.23K 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |